CAS 246146-55-4
:N-[(1S)-4-[(Aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]azepin-11-yl)-1-piperazinyl]-2-oxoethyl]cyclopentaneacetamide
Description:
The chemical substance with the name N-[(1S)-4-[(Aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]azepin-11-yl)-1-piperazinyl]-2-oxoethyl]cyclopentaneacetamide, identified by CAS number 246146-55-4, is a complex organic compound characterized by its multi-functional structure. It features a cyclopentaneacetamide backbone, which is modified with various amino and carbonyl groups, contributing to its potential biological activity. The presence of a dibenzazepine moiety suggests possible interactions with biological targets, particularly in the central nervous system. Additionally, the triazolidine ring and the piperazine group may enhance its pharmacological properties, such as solubility and receptor binding affinity. This compound is likely to exhibit significant therapeutic potential, possibly in the treatment of neurological disorders or as an antimicrobial agent, although specific biological activities would require further investigation through experimental studies. Its complex structure indicates a high degree of specificity in its interactions, making it a candidate for targeted drug design.
Formula:C49H57N11O6
InChI:InChI=1S/C49H57N11O6/c50-46(51)53-25-13-22-40(45(64)52-26-27-58-47(65)59(34-14-3-1-4-15-34)60(48(58)66)35-16-5-2-6-17-35)54-41(61)32-49(23-11-12-24-49)33-42(62)56-28-30-57(31-29-56)43-36-18-7-8-19-37(36)44(63)55-39-21-10-9-20-38(39)43/h1-10,14-21,40,43H,11-13,22-33H2,(H,52,64)(H,54,61)(H,55,63)(H4,50,51,53)/t40-,43?/m0/s1
InChI key:InChIKey=RSJAXPUYVJKAAA-JPGJPTAESA-N
SMILES:O=C1C=2C(C(C=3C(N1)=CC=CC3)N4CCN(C(CC5(CC(N[C@H](C(NCCN6C(=O)N(N(C6=O)C7=CC=CC=C7)C8=CC=CC=C8)=O)CCCNC(=N)N)=O)CCCC5)=O)CC4)=CC=CC2
Synonyms:- Ar-H 053591
- Biie-0246
- Cyclopentaneacetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]azepin-11-yl)-1-piperazinyl]-2-oxoethyl]-
- N-[(1S)-4-[(Aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]azepin-11-yl)-1-piperazinyl]-2-oxoethyl]cyclopentaneacetamide
- N5-(diaminomethylidene)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-N2-[(1-{2-oxo-2-[4-(6-oxo-6,11-dihydro-5H-dibenzo[b,e]azepin-11-yl)piperazin-1-yl]ethyl}cyclopentyl)acetyl]-L-ornithinamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Cyclopentaneacetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]azepin-11-yl)-1-piperazinyl]-2-oxoethyl]-
CAS:Formula:C49H57N11O6Purity:99.10%Molecular weight:896.0470BIIE-0246
CAS:BIIE-0246 is a selective NPY2R antagonist, IC50=15 nM at the rat [125I]PYY3-36 site, reduces NPY-stimulated expression of p-AKT S473 and P-p44/42 MAPK.Formula:C49H57N11O6Purity:98%Color and Shape:SolidMolecular weight:896.05BIIE 0246
CAS:BIIE 0246 is a selective neuropeptide Y (NPY) Y2 receptor antagonist, which is a synthetic compound with specific applications in neuroscience research. This product is derived from combinatorial chemistry techniques that allow for precise structure-activity relationship studies.Formula:C49H57N11O6Purity:Min. 95%Molecular weight:896.06 g/mol



